UK consumers reduced their purchases of food and alcohol during the Christmas season, as experts point to the influence of weight loss injections. Grocery sales amounted to £19.6 billion in the four weeks leading up to December 27, showing a 2.5% increase compared to the previous year, according to NielsenIQ. However, sales based on volume experienced a slight decrease of 0.2%.
Analysts in the retail sector attribute this trend to the growing number of individuals opting for GLP-1 injections, which simulate a crucial hormone responsible for inducing early feelings of fullness in the body. The NHS prescribes weight loss injections like Mounjaro and Wegovy for weight management purposes, while Ozempic is recommended specifically for diabetes. Recent research conducted by University College London suggests that approximately 1.6 million adults in the UK have utilized these injections within the past year.
Jonathan De Mello, a retail analyst at JDM Retail, commented on the notable impact of Ozempic on the grocery sector, noting a surge in GLP-1 usage leading to a decline in year-on-year grocery volume among users. He highlighted that product lines in grocery stores may need adjustments to align with the shift towards a “less but better” consumption pattern.
Consumer analyst Clive Black from Shore Capital highlighted the decrease in grocery sales volume over the Christmas period, attributing it to the effects of GLP drugs on eating behaviors nationwide. In response to this trend, major retailers have introduced smaller meal options. For instance, Co-op launched a range of “mini meals” tailored for individuals with smaller appetites, while Marks & Spencer unveiled a new “nutrient dense” product line. Iceland also expanded its frozen ready meal selection with 38 new offerings.
The impact of weight loss injections is also evident in the business strategies of food retailers. Greggs reported a notable impact on its sales, prompting the company to cater to consumer preferences for smaller portions and nutritional information. Tesco’s CEO, Ken Murphy, emphasized closely monitoring consumer trends, especially in light of the rise in weight loss medication usage, while Sainsbury’s CEO, Simon Roberts, noted a keen observation of shopper habits within their stores.